(Q38219444)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Fecal biomarkers in the diagnosis and monitoring of Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

4

Andrew S Day

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

5

Michael A Kamm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Emily K Wright

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Peter De Cruz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

1 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

1668-1677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Enzymes in feces: useful markers of chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Review article: faecal markers in the assessment of activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Diagnostic yield of colonoscopy based on symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

A simple method for assessing intestinal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Mucosal healing in Crohn's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Fecal lactoferrin: a new parameter to monitor infliximab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000087

10.1097/MIB.0000000000000087

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918319%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference